Insider Selling: Cardlytics (NASDAQ:CDLX) CEO Sells 54,225 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 54,225 shares of the business’s stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $1.04, for a total transaction of $56,394.00. Following the completion of the sale, the chief executive officer directly owned 1,057,220 shares of the company’s stock, valued at approximately $1,099,508.80. This trade represents a 4.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Amit Gupta also recently made the following trade(s):

  • On Wednesday, April 1st, Amit Gupta sold 62,549 shares of Cardlytics stock. The stock was sold at an average price of $0.99, for a total value of $61,923.51.
  • On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total value of $41,997.87.
  • On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The shares were sold at an average price of $0.90, for a total value of $46,844.10.
  • On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Stock Up 13.0%

CDLX traded up $0.13 during trading on Thursday, hitting $1.13. 2,137,597 shares of the stock were exchanged, compared to its average volume of 1,043,434. The firm has a market capitalization of $62.23 million, a P/E ratio of -0.58 and a beta of 0.91. Cardlytics, Inc. has a 1-year low of $0.66 and a 1-year high of $3.28. The stock has a fifty day moving average price of $0.90 and a two-hundred day moving average price of $1.34.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The firm had revenue of $56.10 million during the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. Analysts predict that Cardlytics, Inc. will post -1.52 EPS for the current year.

Wall Street Analysts Forecast Growth

CDLX has been the topic of several research reports. Evercore set a $1.00 price objective on shares of Cardlytics in a research report on Friday, March 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Finally, Bank of America reiterated an “underperform” rating on shares of Cardlytics in a research note on Thursday, March 5th. Two equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $1.75.

View Our Latest Analysis on CDLX

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently modified their holdings of the stock. Vanguard Personalized Indexing Management LLC purchased a new position in Cardlytics in the 3rd quarter valued at $26,000. Sand Hill Global Advisors LLC acquired a new position in Cardlytics in the 2nd quarter valued at $35,000. Virtu Financial LLC purchased a new position in Cardlytics during the 4th quarter worth $39,000. Qube Research & Technologies Ltd acquired a new stake in shares of Cardlytics in the 3rd quarter worth $55,000. Finally, Marshall Wace LLP acquired a new stake in shares of Cardlytics in the 2nd quarter worth $59,000. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Recommended Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.